Tracking RNAZ? Get live short interest, options flow, and signals on ORTEX.Sign up free →
RN
TransCode Therapeutics, Inc. (RNAZ) short interest & options flow
NASDAQTransCode Therapeutics heads into the back half of May carrying a 26% one-month price loss, a freshly filed shelf registration, and short interest that has just ticked back up after a multi-week retreat. The most significant catalyst context is the April 30 S-1 filing. TransCode registered up to 15.96 million shares for resale by selling stockholders — a large number relative to a…
$1.35-12.34% 1d-14.01% 1w-27.42% 1mClose: 10 Nov 2026
- Market cap
- $24M
- Next earnings
- 13 Nov 2026
See the full picture on ORTEX →Live short interest, options flow, signals, 13F filings, and more.
Key data as of 12 Nov 2026
RNAZ news and analysis
RSSNo long-form analysis yet for RNAZ. Pulse alerts and the live data picture are available on ORTEX.
Open RNAZ on ORTEX →Want the live picture for RNAZ?
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for RNAZ — free to start on ORTEX.
Sign up for free →Open RNAZ on ORTEX